Trial Profile
Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary) ; Imaging agents; Sodium fluoride
- Indications Prostate cancer
- Focus Diagnostic use
- 05 May 2020 Status changed from active, no longer recruiting to completed.
- 02 May 2019 Planned End Date changed from 1 May 2021 to 1 Nov 2020.
- 02 May 2019 Planned primary completion date changed from 1 May 2021 to 1 Nov 2020.